Analyst Ratings for Structure Therapeutics (GPCR)
GPCR Rating Summary
GPCR Price Target Summary
- Highest: $145.00 (BMO Capital)
- Lowest: $70.00 (H.C. Wainwright)
- Average: $103.64
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$103.64 (+125.5%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
Avg. $ Target:
$103.64 (+125.5%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/27/2026 | Canaccord | Edward Nash | New Coverage | Buy (N/A) |
101.00 (N/A) |
45.49 (45.96) |
1.03% | Details |
| 3/26/2026 | Wolfe Research | Alexan | New Coverage | Peerperform (N/A) |
N/A (N/A) |
48.13 (45.96) |
-4.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
